来自肝脏的微粒体，合并

Microsomes from Liver, Pooled has been used:

• in the glucuronidation kinetics assay to test the effects of herbal extracts on glucuronidation process
• as a human liver microsomes (HLM) matrix for testing metabolic stability of talazoparib using liquid chromatography-tandem mass spectrometry (LC–MS/MS)
• to study the metabolization of enantiomeric peptide D3

Microsomes from liver have been used in a study to assess differences in enzymatic activities between normal rat livers and from liver after partial hepatectomy. They have also been used in a study to investigate the carbon monoxide-binding pigment in liver microsomes.

N-glucuronidation of various 1-substituted imidazoles was found to occur in human liver microsomes.

肝微粒体是来源于肝细胞内质网的亚细胞颗粒。这些微粒体是药物代谢酶（包括细胞色素 P-450）的丰富来源。不同来源的微粒体池有助于研究外源代谢和药物相互作用。

药物代谢酶的来源，包括细胞色素 P-450。